Featured Research

from universities, journals, and other organizations

Genes at the flick of a light switch: Human cells fitted with synthetic signaling cascade

Date:
June 24, 2011
Source:
ETH Zürich
Summary:
Researchers from Switzerland have fitted human cells with a synthetic signaling cascade that can be used to switch on and regulate genes via blue light. This "gene light switch" makes interesting therapies possible, which could be used to treat type 2 diabetes, for instance.

Under a blue light, biotechnologically modified cells implanted in mice produce proteins that could one day be used for treatment purposes.
Credit: ETH Zurich/Martin Fussenegger

Researchers from ETH Zurich have fitted human cells with a synthetic signaling cascade that can be used to switch on and regulate genes via blue light. This "gene light switch" makes interesting therapies possible, which could be used to treat type 2 diabetes, for instance.

Related Articles


The latest feat to come out of Martin Fussenegger's lab almost sounds like science fiction: the professor of biotechnology and bioengineering and his team have constructed a genetic network in living cells that can be used to switch on and regulate specific genes via blue light. However, rather than create the whole network the bioengineers have merely connected up natural signaling pathways -- one from the eye and one from the immune system. The cells are inserted under the skin, complete with the functioning gene network, and blue light is shone onto the implant from outside. This enables the researchers to control the target gene with extreme precision, reports first author Haifeng Ye from Fussenegger's team in the latest issue of Science.

The "gene light switch" the scientists use to switch on the network is made of melanopsin, a protein found in the retina of the human eye that forms a complex with Vitamin A. When blue light hits this complex, the first signaling cascade is activated, which ensures that calcium accumulates inside the cell -- a process that also takes place naturally in the eye and is responsible for setting the biological clock in the brain every day. However, the scientists have re-connected it -- to a signaling pathway that plays a key role in immunoregulation.

Light against winter blues

The calcium inside the cell activates an enzyme that separates the phosphate group (P) from the protein NFAT-P. NFAT thus enters the cell nucleus, where it binds to a synthetic control sequence and switches on the target gene the researchers have introduced. The gene becomes active and the cell produces numerous copies of the protein, for which the gene is the blueprint. By controlling the amount of light and its intensity, the researchers can also regulate how much of the protein is produced. Switching the gene off is easy: light off, gene off. After all, without light melanopsin is no longer stimulated, no more calcium accumulates in the cells and the signal cascade is interrupted.

This artificial signaling cascade is synthesised in human cells which, suitably parcelled, are implanted in mice. The blue light reaches the cell implants either via an ultra-thin glass fibre optic cable or, if the implant is placed directly under the skin, simply by placing the animals under a blue lamp. For the light source, the researchers used commercially available LEDs or a blue-light lamp that is used to combat winter depression. Since it does not contain a UV proportion, the light is not harmful for the skin.

Diabetes treatment conceivable

In their experiments with cell cultures and mice, the researchers tested the light-controlled production of GLP-1, a hormone that controls the production of insulin directly and thus regulates the blood glucose level. And it showed the researchers that their approach works: the GLP-1 that was upregulated using light helped diabetic mice to improve the organism's insulin production, quickly remove the glucose from the blood and restore the blood-sugar balance in the organism.

Martin Fussenegger can imagine the GLP-1 gene therapy his team has developed replacing the classical injection of insulin for diabetics one day. People suffering from type 2 diabetes, for instance, could have an implant placed under the skin as outpatients. A black plaster containing LED lamps shields the relevant area of the skin from the daylight. As and when needed, such as after a meal, for instance, the patient switches on the LED lamps by pushing a button and shines them on the implant for a few minutes to stimulate the production of GLP-1. As soon as enough of the hormone is circulating in the body, the patient simply switches the lamps back off. "That's still the stuff of science fiction, though," stresses the ETH Zurich professor; it will be quite some time before we see a product like this on the market.


Story Source:

The above story is based on materials provided by ETH Zürich. Note: Materials may be edited for content and length.


Journal Reference:

  1. Haifeng Ye, Marie Daoud-El Baba, Ren-Wang Peng, Martin Fussenegger. A Synthetic Optogenetic Transcription Device Enhances Blood-Glucose Homeostasis in Mice. Science, 2011; 332 (6037): 1565-1568 DOI: 10.1126/science.1203535

Cite This Page:

ETH Zürich. "Genes at the flick of a light switch: Human cells fitted with synthetic signaling cascade." ScienceDaily. ScienceDaily, 24 June 2011. <www.sciencedaily.com/releases/2011/06/110623141200.htm>.
ETH Zürich. (2011, June 24). Genes at the flick of a light switch: Human cells fitted with synthetic signaling cascade. ScienceDaily. Retrieved November 21, 2014 from www.sciencedaily.com/releases/2011/06/110623141200.htm
ETH Zürich. "Genes at the flick of a light switch: Human cells fitted with synthetic signaling cascade." ScienceDaily. www.sciencedaily.com/releases/2011/06/110623141200.htm (accessed November 21, 2014).

Share This


More From ScienceDaily



More Matter & Energy News

Friday, November 21, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Toyota's Hydrogen Fuel-Cell Green Car Soon Available in the US

Toyota's Hydrogen Fuel-Cell Green Car Soon Available in the US

AFP (Nov. 21, 2014) — Toyota presented its hydrogen fuel-cell compact car called "Mirai" to US consumers at the Los Angeles auto show. The car should go on sale in 2015 for around $60.000. It combines stored hydrogen with oxygen to generate its own power. Duration: 01:18 Video provided by AFP
Powered by NewsLook.com
Google Announces Improvements To Balloon-Borne Wi-Fi Project

Google Announces Improvements To Balloon-Borne Wi-Fi Project

Newsy (Nov. 21, 2014) — In a blog post, Google said its balloons have traveled 3 million kilometers since the start of Project Loon. Video provided by Newsy
Powered by NewsLook.com
NSA Director: China Can Damage US Power Grid

NSA Director: China Can Damage US Power Grid

AP (Nov. 20, 2014) — China and "one or two" other countries are capable of mounting cyberattacks that would shut down the electric grid and other critical systems in parts of the United States, according to Adm. Michael Rogers, director of the National Security Agency and hea Video provided by AP
Powered by NewsLook.com
Latest Minivan Crash Tests Aren't Pretty

Latest Minivan Crash Tests Aren't Pretty

Newsy (Nov. 20, 2014) — Five minivans were put to the test in head-on crash simulations by the Insurance Institute for Highway Safety. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Space & Time

Matter & Energy

Computers & Math

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins